Toggle light / dark theme

Eva Ramón Gallegos’s research works

Eva Ramón, a #Mexican Scientist may have done something amazing.

The present study aimed to determine the effectiveness of photodynamic therapy (PDT), using δ-aminolevulinic acid (5-ALA), in the elimination of premalignant cervical lesions in Mexican patients with human papillomavirus (HPV) infection and/or cervical intraepithelial neoplasia (CIN). Thirty women diagnosed with CIN I and/or positive for HPV participated in the study.

Microbiome could be culprit when good drugs do harm

Or bad drugs given to good people by doctors who were clueless 🙈

‘’The study found that the gut microbes were responsible for producing 20 percent to 80 percent of the circulating toxic metabolites derived from the three drugs.


People sometimes suffer toxic side effects from drugs that help many others. Yale scientists have identified a surprising explanation—the gut microbiome.

The research, published Feb. 8 in the journal Science, describes how bacteria in the gut can transform three drugs into harmful compounds.

“If we can understand the microbiome’s contributions to drug metabolism, we can decide which drugs to give to patients or even alter the microbiome so patients have a better response,” said co-lead author Michael Zimmermann, postdoctoral fellow in the lab of senior author Andrew Goodman in the Department of Microbial Pathogenesis and the Microbial Sciences Institute.

Nested CRISPR enables efficient genome editing using long DNA fragments

CRISPR is a technique that is revolutionizing biomedical research through high-precision genome editing. However, even though it allows the creation or correction of mutations consisting of a single or few nucleotides with relative ease, it still possesses limitations for larger fragments of DNA in the genome. For instance, the genomic insertion of a gene that produces a fluorescent protein such as the widely-used GFP suffers from poor efficiency and involves complicated cloning steps.

Chronic rhinosinusitis linked to depression, anxiety

(HealthDay)—Chronic rhinosinusitis (CRS) is associated with incidence of depression and anxiety, according to a study published online Feb. 7 in JAMA Otolaryngology-Head & Neck Surgery.

Jong-Yeup Kim, M.D., Ph.D., from Konyang University Hospital in Daejeon, South Korea, and colleagues conducted a retrospective nationwide cohort study using population-based insurance data for 16,224 patients with CRS and 32,448 individuals without CRS, with propensity score matching between the groups. The incidence, survival rate, and hazard ratios of depression and anxiety were calculated for each group.

The researchers found that during the 11-year follow-up, the overall incidence of depression was higher in the CRS versus the non-CRS group (24.2 versus 16.0 per 1,000 person-years; adjusted hazard ratio, 1.54). Higher incidence of anxiety was also seen in the CRS versus the non-CRS group (42.2 versus 27.8 per 1,000 person-years; adjusted hazard ratio, 1.57). Compared with patients with CRS with nasal polyps, patients with CRS without had higher adjusted hazard ratios for developing depression (1.61 versus 1.41) and anxiety (1.63 versus 1.45).

Aging and chronic diseases share genetic factors, study reveals

The global population aged 60 or over is growing faster than all younger age groups and faces the tide of chronic diseases threatening their quality of life and posing challenges to healthcare and economy systems. To better understand the underlying biology behind healthspan — the healthy period of life before the first chronic disease manifestation — the scientists from Gero and MIPT collaborated with the researchers from PolyOmica, the University of Edinburgh and other institutes to analyze genetic data and medical histories of over 300,000 people aged 37 to 73 made available by UK Biobank.

The study published today in Communications Biology was lead by Dr. Peter Fedichev and Prof. Yurii Aulchenko. It shows that the most prevalent chronic conditions such as cancer, diabetes, chronic obstructive pulmonary disease, stroke, dementia, and some others apparently share the common underlying mechanism that is aging itself.

«According to Gompertz mortality law, the risk of death from all causes increases exponentially after the age of 40 and doubles approximately every 8 years», explains Peter Fedichev, founder and CSO of Gero. «By analyzing the dynamics of disease incidence in the clinical data available from UKB, we observed that the risks of age-related diseases grow exponentially with age and double at a rate compatible with the Gompertz mortality law. This close relation between the most prevalent chronic diseases and mortality suggests that their risks could be driven by the same process, that is aging. This is why healthspan can be used as a natural proxy for investigation of the genetic factors controlling the rate of aging, the “holy grail” target for anti-aging interventions».

Doctors Wired a Prosthetic Hand Directly Into a Woman’s Nerves

In a world first, doctors in Sweden say they’ve wired a prosthetic hand directly into a woman’s nerves, allowing her to move its fingers with her mind and even feel tactile sensations.

The hand is an enormous step up from existing prostheses, which often rely on electrodes placed on the outside of the skin — and it could herald a future in which robotic devices interface seamlessly with our bodies.

/* */